Target ID:dt307
CID:4595
Compound Name:Ondansetron
Gene ID:836
Gene Name:CASP3
Species:Homo sapiens (human)
PubMed IDs:34654991
Action:Paclitaxel inhibits the reaction [ondansetron results in increased expression of CASP3 protein modified form]|ondansetron results in increased expression of CASP3 protein modified form

Knowledge Graph

Target IDCIDCompound NameGene IDGene NameSpeciesAction
dt1036 23665637 Amoxicillin-Potassium Clavulanate Combination 836 CASP3 Rattus norvegicus (Norway rat) Amoxicillin-potassium clavulanate combination results in increased activity of CASP3 protein Details
dt1145 54675783 Minocycline 836 CASP3 Homo sapiens (human) Negative modulator Details
dt1203 91663255 Sucroferric oxyhydroxide 836 CASP3 Bos taurus (cattle) Ferric oxide, saccharated results in increased cleavage of and results in increased activity of CASP3 protein|ferric oxide, saccharated results in increased expression of CASP3 protein Details
dt308 4595 Ondansetron 836 CASP3 Rattus norvegicus (Norway rat) Ondansetron inhibits the reaction [cisplatin results in increased cleavage of CASP3 protein] Details
dt420 6912 Adonitol 836 CASP3 Homo sapiens (human) Xylitol results in increased expression of CASP3 protein modified form Details
dt436 10112 Calcium Carbonate 836 CASP3 Homo sapiens (human) Calcium carbonate analog results in increased activity of CASP3 protein Details
dt769 5281613 Diosmin 836 CASP3 Mus musculus (house mouse) Diosmin inhibits the reaction [benzo(a)pyrene results in increased cleavage of CASP3 protein] Details
dt770 5281613 Diosmin 836 CASP3 Rattus norvegicus (Norway rat) Diosmin inhibits the reaction [2-acetylaminofluorene results in increased activity of CASP3 protein] Details
dt771 5281613 Diosmin 836 CASP3 Rattus norvegicus (Norway rat) Diosmin inhibits the reaction [acetic acid results in increased expression of CASP3 protein] Details
dt772 5281613 Diosmin 836 CASP3 Rattus norvegicus (Norway rat) Diosmin inhibits the reaction [lipopolysaccharides results in increased activity of CASP3 protein] Details

Drug IDDrug NameTypeDrugBank IDTargetsCategoryLatest Progress
Drug33 Ondansetron Chemical drug -- -- -- Under clinical trials Details

Compound IDSource IDSource TypeCompound NameMolecular WeightMolecular FormulaMolecular Species
No data available

Disease IDDisease NameDefinitionMechanism
No data available

Strategy IDTherapy StrategySynonymsRelated DrugsMechanism
No data available